Senior Oncology Account Manager, Hematology - Phoenix
Jazz Pharmaceuticals
Summary
The Senior Oncology Account Manager (OAM) is responsible for direct promotion of Jazz Pharmaceuticals' products and the development and management of business relationships with therapeutic specialists within an assigned geographical territory covering Arizona, Nevada, and New Mexico.
Job description
Key Responsibilities
- Implement marketing strategies and tactics to achieve sales goals through short-term and long-term objectives.
- Possess strong sales analytics capabilities with demonstrated understanding of prescribing and purchasing decision processes.
- Develop and implement customized account strategic plans with clear next steps, strategies, and tactics.
- Collaborate with cross-functional teams including marketing, medical affairs, and market access to align and execute account strategies.
- Educate physicians and other healthcare professionals about Jazz Pharmaceuticals products, providing current information on approved indications for pediatric and young adult acute lymphoblastic leukemia (ALL) and bone marrow transplant.
- Utilize CRM tools to effectively manage customer interactions, track sales activities, and maintain accurate territory records.
- Represent company at live and virtual conferences, attend company meetings, educational events, and training programs as needed.
- Comply with all legal/regulatory guidelines including the Food, Drug and Cosmetic Act, Prescription Drug Marketing Act, Pharma Code, and OIG guidelines.
Required Experience
- Four-year college/university degree
- Experience in Oncology
- Excellent verbal and written communication skills with an effective presentation style
- Ability to meet territorial travel requirements
Preferred Experience
- Post-graduate business school study or training
- Minimum of 5 years in the oncology market
- Strong clinical, technical and scientific knowledge of product(s) and applicable disease states
- Strategic thinker who can drive a strategic account business plan
- Strong key account management experience in complex academic and community accounts
- Demonstrated history of strong business acumen, problem solving, effective prioritization, account management, and sales data analytics skills
- Skillful in fostering teamwork and collaboration in cross-functional account management
- Results oriented with a proactive and self-motivated approach to driving sales growth
- Experience with pediatric and young adult ALL and bone marrow transplant highly preferred
Requirements
- Four-year college/university degree
- Experience in Oncology
- Excellent verbal and written communication skills
- Effective presentation style for face-to-face and virtual interactions
- Ability to meet territorial travel requirements
Benefits
- Medical, Dental & Vision
- 401(k) Retirement Savings Plan
- Flexible Paid Vacation
- Discretionary Annual Cash Bonus
- Incentive Compensation
- Discretionary Equity Grants
Company overview
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, with significant operations in the United States and Europe. Founded in 2003 in California, the company specializes in developing and commercializing innovative medicines for patients with serious diseases, with a primary focus on oncology and neuroscience. Jazz Pharmaceuticals is renowned for its flagship product Xyrem (sodium oxybate), which treats excessive daytime sleepiness and cataplexy in narcolepsy patients, generating substantial revenue for the company. The company's portfolio also includes treatments for epilepsy, sleep disorders, hematology, and oncology, with notable products such as Erwinaze, Defitelio, FazaClo, and Vyxeos. Through strategic acquisitions including GW Pharmaceuticals in 2021, Jazz expanded its neuroscience portfolio with cannabis-based medicines like Epidiolex for severe epilepsy syndromes. With approximately 2,800 employees worldwide and operations across multiple continents, Jazz Pharmaceuticals maintains a strong commitment to research and development, focusing on transforming biopharmaceutical discoveries into novel therapies for patients with limited treatment options. The company operates manufacturing facilities in Ireland, England, and Italy, and continues to pursue innovative approaches to address critical unmet medical needs in specialized therapeutic areas.